Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Healthpeak Properties Inc V.DOC


Primary Symbol: DOC

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT). The Company acquires, develops, owns, leases, and manages healthcare real estate across the United States. Its strategy is to invest in and manage real estate focused on healthcare discovery and delivery. It has a diversified portfolio of high-quality healthcare properties across three core asset classes of lab, outpatient medical, and continuing care retirement community (CCRC) real estate. The Company’s segments include Lab, Outpatient medical and CCRC. The lab segment properties contain laboratory and office space, are leased primarily to biotechnology, medical device and pharmaceutical companies, scientific research institutions, government agencies, and other organizations involved in the life science industry. The Outpatient Medical segment includes outpatient medical buildings and hospitals. Outpatient medical buildings typically contain physicians’ offices and examination rooms.


NYSE:DOC - Post by User

Comment by DougInGreenon Apr 08, 2021 5:56pm
161 Views
Post# 32963766

RE:RE:RE:RE:RE:RE:RE:RE:Moving at pace

RE:RE:RE:RE:RE:RE:RE:RE:Moving at pace

No evidence and I am new to how fully consolidated acquisitions work. That comment was based on the fact we seem to be paying very different prices for different amounts of earnings. --- RXI was purchased for 9 million total payout contributing 16.6 million in revenue but with poor EBITDA
- VisionPros for 100 million total payout for 22 million revenue with EBITDA of 10%
- Oncidiumand for 100 million payout for 40 million revenue and 14% EBITDA.

My assumption was that the hugely different prices would reflect either a difference in assets or liabilities in the acquired company but they are all private so I have no information to base this off of. If there is another explanation I would love to have that clarified.

Tuatara wrote: Q3 report, they had $1.83MM of Debt against $55MM in Assets.

I havent read anything in any of the terms sheets that reports debt-carry with any of the acquisitions. Bankers etc are all paid in shares so any costs should be limited to legal and consultancy fees imho.

Have you seen any debt highlihghted within any of the recent term sheets that I may have missed?

 

<< Previous
Bullboard Posts
Next >>